HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Maria R Mascarenhas Selected Research

Exocrine Pancreatic Insufficiency

3/2022Pancreatic Enzyme Replacement Therapy in Cystic Fibrosis.
1/2020Improved residual fat malabsorption and growth in children with cystic fibrosis treated with a novel oral structured lipid supplement: A randomized controlled trial.
12/2016Effect of Oral Lipid Matrix Supplement on Fat Absorption in Cystic Fibrosis: A Randomized Placebo-Controlled Trial.
4/2016Choline Supplementation With a Structured Lipid in Children With Cystic Fibrosis: A Randomized Placebo-Controlled Trial.
8/2015Malabsorption blood test: Assessing fat absorption in patients with cystic fibrosis and pancreatic insufficiency.
6/2014Vitamin B(12) status in children with cystic fibrosis and pancreatic insufficiency.
7/2013Delayed small bowel transit in children with cystic fibrosis and pancreatic insufficiency.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Maria R Mascarenhas Research Topics

Disease

8Cystic Fibrosis (Mucoviscidosis)
03/2022 - 04/2013
7Exocrine Pancreatic Insufficiency
03/2022 - 07/2013
2Pancreatitis
01/2020 - 11/2018
1Critical Illness (Critically Ill)
10/2021
1Pressure Ulcer (Bedsore)
10/2021
1Congenital Heart Defects (Congenital Heart Defect)
01/2021
1Pain (Aches)
01/2020
1Chronic Pain
01/2020
1Cognitive Dysfunction
06/2019
1Asthma (Bronchial Asthma)
06/2019
1Breast Neoplasms (Breast Cancer)
06/2019
1Cardiovascular Diseases (Cardiovascular Disease)
06/2019
1Obesity
06/2019
1Colorectal Neoplasms (Colorectal Cancer)
06/2019
1Fatty Liver
04/2016
1Malnutrition (Nutritional Deficiencies)
03/2016
1Failure to Thrive
02/2013
1Refeeding Syndrome
08/2003
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
02/2002

Drug/Important Bio-Agent (IBA)

5LipidsIBA
01/2020 - 04/2013
3AcidsIBA
04/2016 - 04/2013
2Dietary Fats (Dietary Fat)IBA
01/2020 - 12/2016
2EnzymesIBA
04/2016 - 07/2013
2pentadecanoic acidIBA
08/2015 - 04/2013
1Opioid Analgesics (Opioids)IBA
01/2020
1Fatty Acids (Saturated Fatty Acids)IBA
01/2020
1DNA (Deoxyribonucleic Acid)IBA
11/2018
1Choline (Choline Chloride)IBA
04/2016
1MicronutrientsIBA
03/2016
1Triglycerides (Triacylglycerol)IBA
08/2015
1margaric acid (heptadecanoic acid)IBA
08/2015
1Nonesterified Fatty Acids (NEFA)IBA
08/2015
1Lipase (Acid Lipase)FDA Link
08/2015
1Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric
06/2014
1Biological ProductsIBA
02/2002

Therapy/Procedure

3Therapeutics
03/2022 - 02/2002
2Parenteral Nutrition
02/2013 - 08/2003
1Enzyme Replacement Therapy
03/2022
1Nutrition Therapy (Medical Nutrition Therapy)
10/2021
1Length of Stay
01/2021
1Pain Management
01/2020
1Mediterranean Diet
06/2019
1Enzyme Therapy
12/2016
1Oral Administration
04/2013